Strategy is a solution that takes you from your current situation “A” to a new situation “B.” ~ Robert Cantrell Outpacing the Competition: Patent-Based Business Strategy, by Robert L. Cantrell (Wiley, John & Sons, Inc., 343pp), is a book written for business-people and attorneys who are charged with developing business opportunities using practical patent strategies. […]

Gene Quinn, at IPWatchdog, has been working on developing a list of the top 50 patent blogs based on a combination of objective and subjective criteria. These are all great blogs and trying to put them in any kind of “ranking” makes little sense since many are narrowly tailored and have different emphasis and audiences.  […]

Innovation patents are second tier patents similar to utility models, having a lower threshold for patentability and a relatively short term of eight years compared to standard patents. A recent appeal court decision confirms that inventions that include features that are known and obvious can still sustain valid innovation patent protection in Australia. The Decision […]

“To amend the public health service act to establish a pathway for the licensure of biosimilar biologic products, to promote innovation in the life sciences.” Amendment No. 297. The U.S. Senate Health, Education, Labor, and Pensions (HELP) Committee voted Monday in favor of a proposal by Sens. Kay Hagan (D-NC), Michael Enzi (R-WY), and Orrin […]

Battelle Memorial Institute, an an international science and technology enterprise that explores emerging areas of science, develops and commercializes technology, and manages laboratories, is offering a seminar on medical device development through it’s Life Science Solutions division. What: Medical Device Development 101 Seminar Who: Presented by BIOSTART Where: Health Foundation of Greater Cincinnati 3805 Edwards […]

The recent (and ongoing) scare about swine flu has invited queries about the arrangements which governments have in place to deal with outbreaks of epidemic diseases in their populations. Many governments, including Ireland, have agreements in place with pharmaceutical companies to produce and supply anti-viral or other appropriate treatments within a certain time-frame. The usual […]

The saga of the PTO’s rulemaking authority continued on March 20, 2009 when the Federal Circuit issued its 55 page decision in Tafas v. Doll holding that aside from the rule limiting continuations, the other rule changes were procedural in nature and the PTO does have the rule-making authority to implement the rules limiting the […]

Earlier, the Australian courts were asked consider the meaning of “the filing date of the complete application” in clause 2.2(1A) of the Patents Regulations 1991 in the context of a divisional application. (Mont Adventure Equipment Pty Limited v Phoenix Leisure Group Pty Limited [2008] FCA 1476) In the case at hand, the Applicant, Mont Adventure, […]